Plain-English translation of NCT06997029 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a Phase 1 trial testing a new drug called in people with advanced solid tumors. Researchers want to see if the medication works well when given alone, or whether it works better when combined with certain breast cancer drugs that patients have already tried. Because this is a Phase 1 study, the main goal is to find the right dose and understand how safe the medication is.
Advanced solid tumors and certain types of breast cancer can be very hard to treat, especially after patients have already tried other medications. This trial exists to find out whether this new treatment option could help patients whose cancers are no longer responding to standard drugs.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the trial you join, you will take the medication either alone or in combination with a drug you may have already been taking. The study involves multiple visits to the research center for health check-ups, blood tests, and imaging scans to see how you're responding. Your exact schedule and timeline will depend on which study group you're assigned to and how your body responds to the treatment.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States